Dopavision
5 known investors
Find your way into Dopavision
Sign up to see every warm intro you have to Dopavision
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dopavision team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways. Its lead product targets slowing the progression of myopia in children and adolescents.
Investors · 5
How we know: Seventure Partners's portfolio page · funding news · dopavision.com · Not right? Tell us
How we know: funding news · dopavision.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJul 2021 · 4 sources
Seventure Partners (lead), Ababax Health, Boehringer Ingelheim Venture Fund, Novartis Pharmaceuticals
Source ↗ - Undisclosed amountseed investmentJun 2019
Boehringer Ingelheim Venture Fund (lead), Flying Health
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Dopavision do?
- Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways. Its lead product targets slowing the progression of myopia in children and adolescents.
- Who are Dopavision's investors?
- Dopavision's investors include Seventure Partners, Boehringer Ingelheim Venture Fund.
